Vertos Medical Regains Medicare Reimbursement Eligibility

Represented Vertos Medical in raising over $125 million for the design, development, manufacture and marketing of a product for minimally invasive spinal decompression procedures. Though the company operates commercially, it lost Medicare coverage reimbursement eligibility which it needed to regain. After several difficult financing rounds, we helped the company structure its recent $27 million Series B inside round to complete all but the participation right offered to the other holders of preferred stock. We also calmed the company’s board of directors and key investors amid concerns of board liability.